Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

[Tryptophan-induced fasciitis-scleroderma-eosinophilia syndrome].

Eosinophilic fasciitis associated with L-tryptophan ingestion.

Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.

L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.

Eosinophilic fasciitis associated with the eosinophilia-myalgia syndrome.

L-tryptophan ingestion does not induce progressive systemic sclerosis (scleroderma).

Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.

Tryptophan-associated eosinophilia-myalgia syndrome and pancreatitis.

Two patients with eosinophilia myalgia syndrome associated with tryptophan.

Tryptophan use and fasciitis.

Tryptophan and eosinophilia-myalgia syndrome.

Tryptophan and eosinophilia myalgia syndrome.

The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.

Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia.

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

The eosinophilia-myalgia syndrome and tryptophan.

[Polyneuropathy and fasciitis in eosinophilia-myalgia syndrome].

Tryptophan-induced eosinophilia-myalgia syndrome.

Tryptophan-induced eosinophilia-myalgia syndrome.

Absent neutrophil alkaline phosphatase in the eosinophilia myalgia syndrome associated with L-tryptophan use.

L-tryptophan use and the eosinophilia-myalgia syndrome.

[Tryptophan-load in progressive scleroderma (author's transl)].

Eosinophilia associated with clozapine.

Eosinophilic fasciitis associated with use of L-tryptophan: a case-control study and comparison of clinical and histopathologic features.

Suggest Documents

[Tryptophan-induced fasciitis-scleroderma-eosinophilia syndrome].

Eosinophilic fasciitis associated with L-tryptophan ingestion.

Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.

L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.

Eosinophilic fasciitis associated with the eosinophilia-myalgia syndrome.

L-tryptophan ingestion does not induce progressive systemic sclerosis (scleroderma).

Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.

Tryptophan-associated eosinophilia-myalgia syndrome and pancreatitis.

Two patients with eosinophilia myalgia syndrome associated with tryptophan.

Tryptophan use and fasciitis.

Tryptophan and eosinophilia-myalgia syndrome.

Tryptophan and eosinophilia myalgia syndrome.

The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.

Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia.

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

The eosinophilia-myalgia syndrome and tryptophan.

[Polyneuropathy and fasciitis in eosinophilia-myalgia syndrome].

Tryptophan-induced eosinophilia-myalgia syndrome.

Tryptophan-induced eosinophilia-myalgia syndrome.

Absent neutrophil alkaline phosphatase in the eosinophilia myalgia syndrome associated with L-tryptophan use.

L-tryptophan use and the eosinophilia-myalgia syndrome.

[Tryptophan-load in progressive scleroderma (author's transl)].

Eosinophilia associated with clozapine.

Eosinophilic fasciitis associated with use of L-tryptophan: a case-control study and comparison of clinical and histopathologic features.

Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

Recommend Documents

Follow Us